166.75
Ligand Pharmaceuticals Inc (LGND) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
5.06%
47.63
|
45.33 | 42.81 | 51.81 | 41.53 |
|
51.95%
39.18
|
81.55 | 52.45 | 48.67 | 60.63 |
Benefits Costs and Expenses |
61.89%
36.40
|
95.51 | 82.01 | 58.15 | 106.92 |
Costs And Expenses |
61.89%
36.40
|
95.51 | 82.01 | 58.15 | 106.92 |
Operating Income/Loss |
123.32%
8.444
|
-36.22 | -9.637 | 3.143 | -19.10 |
Nonoperating Income/Loss |
119.90%
2.779
|
-13.96 | -29.56 | -9.482 | -46.29 |
Income/Loss From Equity Method Investments |
-
|
- | -1.245 | -1.194 | -8.03 |
Income/Loss From Continuing Operations Before Tax |
122.37%
11.22
|
-50.18 | -39.20 | -6.339 | -65.39 |
Income Tax Expense/Benefit |
182.49%
6.376
|
-7.729 | -8.112 | 0.833 | -13.48 |
Income/Loss From Continuing Operations After Tax |
111.42%
4.847
|
-42.45 | -31.09 | -7.172 | -51.91 |
|
111.42%
4.847
|
-42.45 | -31.09 | -7.172 | -51.91 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.71%
19.33
|
19.19 | 0.229 | 18.42 | 18.03 |
Diluted Average Shares |
3.83%
19.93
|
19.19 | -0.284 | 18.42 | 18.03 |
Basic Earnings Per Share |
111.31%
0.25
|
-2.21 | -1.72 | -0.39 | -2.88 |
Diluted Earnings Per Share |
110.86%
0.24
|
-2.21 | -1.68 | -0.39 | -2.88 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):